However, subsequent attempts to assess the role of PPARβ/δ in cancer have demonstrated that this receptor both inhibits and promotes tumorigenesis, as it has been extensively reviewed previously [10,86,87], becoming one of the most controversial effects of PPARβ/δ. The gene discussed is PPARD; the disease is cancer.